Adler Oz has filed an SEC Form 3, disclosing his ownership in Evogene Ltd. This filing, dated October 22, 2026, is significant as it shows Oz's active role as a director within the company.
Adler Oz is associated with Evogene Ltd., a company classified under the SIC code for Agriculture Chemicals. The recent filing marks an important update, reflecting the company's commitment to transparency and governance.
The filing states: "
noSecuritiesOwned: 1" indicating that Oz holds one security. This ownership is part of his role as a director, showcasing his involvement in the company's operations.
This update may affect stakeholders in Evogene Ltd. and the broader agriculture chemicals industry, as it highlights the importance of governance and transparency in corporate practices.
The filing does not say what happens next.
The filing also indicates that Adler Oz is a director of Evogene Ltd., confirming his leadership role within the company. This is significant as it highlights his influence on the company's strategic decisions and governance practices.
According to the filing, the address for Adler Oz is listed as VINIK 22, RISHON LETSION, ISRAEL, providing insight into his location and potential operational jurisdiction.
Evogene Ltd. is incorporated in L3, with its business address located at 13 Gad Feinstein Street, Park Rehovot, Rehovot, L3, Israel. This information may be relevant for stakeholders looking to understand the company's operational base.
Additionally, the filing confirms that Adler Oz does not hold any officer title nor is he a ten percent owner of Evogene Ltd., which may clarify the extent of his ownership and influence within the company.
The filing does not provide details on any specific plans or initiatives that Adler Oz may undertake in his role as a director, nor does it include any information about Evogene Ltd.'s future projects or financial outlook.